Subependymal giant cell astrocytoma historical perspective: Difference between revisions
Line 7: | Line 7: | ||
==Historical Perspective== | ==Historical Perspective== | ||
*In 2012, experts at the International Tuberous Sclerosis Complex Consensus Conference described subependymal giant cell atroctyoma as a lesion located in the caudothalamic groove having a size of >1 cm in any direction or a subependymal lesion that has shown serial growth on consecutive imaging regardless of size and location.<ref name="pmid31428037">{{cite journal| author=Jansen AC, Belousova E, Benedik MP, Carter T, Cottin V, Curatolo P et al.| title=Newly Diagnosed and Growing Subependymal Giant Cell Astrocytoma in Adults With Tuberous Sclerosis Complex: Results From the International TOSCA Study. | journal=Front Neurol | year= 2019 | volume= 10 | issue= | pages= 821 | pmid=31428037 | doi=10.3389/fneur.2019.00821 | pmc=6688052 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=31428037 }} </ref> | *In 2012, experts at the International Tuberous Sclerosis Complex Consensus Conference described subependymal giant cell atroctyoma as a lesion located in the caudothalamic groove having a size of >1 cm in any direction or a subependymal lesion that has shown serial growth on consecutive imaging regardless of size and location.<ref name="pmid31428037">{{cite journal| author=Jansen AC, Belousova E, Benedik MP, Carter T, Cottin V, Curatolo P et al.| title=Newly Diagnosed and Growing Subependymal Giant Cell Astrocytoma in Adults With Tuberous Sclerosis Complex: Results From the International TOSCA Study. | journal=Front Neurol | year= 2019 | volume= 10 | issue= | pages= 821 | pmid=31428037 | doi=10.3389/fneur.2019.00821 | pmc=6688052 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=31428037 }} </ref> | ||
==References== | ==References== |
Revision as of 15:00, 29 October 2019
Subependymal giant cell astrocytoma Microchapters |
Differentiating Subependymal Giant Cell Astrocytoma from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Subependymal giant cell astrocytoma historical perspective On the Web |
American Roentgen Ray Society Images of Subependymal giant cell astrocytoma historical perspective |
FDA on Subependymal giant cell astrocytoma historical perspective |
CDC on Subependymal giant cell astrocytoma historical perspective |
Subependymal giant cell astrocytoma historical perspective in the news |
Blogs on Subependymal giant cell astrocytoma historical perspective |
Risk calculators and risk factors for Subependymal giant cell astrocytoma historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2]
Overview
Russell et al was the first scientist to coin the term "subependymal giant cell astrocytoma".[1]
Historical Perspective
- In 2012, experts at the International Tuberous Sclerosis Complex Consensus Conference described subependymal giant cell atroctyoma as a lesion located in the caudothalamic groove having a size of >1 cm in any direction or a subependymal lesion that has shown serial growth on consecutive imaging regardless of size and location.[2]
References
- ↑ Ouyang, Taohui; Zhang, Na; Benjamin, Thomas; Wang, Long; Jiao, Jiantong; Zhao, Yiqing; Chen, Jian (2014). "Subependymal giant cell astrocytoma: current concepts, management, and future directions". Child's Nervous System. 30 (4): 561–570. doi:10.1007/s00381-014-2383-x. ISSN 0256-7040.
- ↑ Jansen AC, Belousova E, Benedik MP, Carter T, Cottin V, Curatolo P; et al. (2019). "Newly Diagnosed and Growing Subependymal Giant Cell Astrocytoma in Adults With Tuberous Sclerosis Complex: Results From the International TOSCA Study". Front Neurol. 10: 821. doi:10.3389/fneur.2019.00821. PMC 6688052 Check
|pmc=
value (help). PMID 31428037.